Stenting in Coarctation of Aorta (CoA)

Comparison between Cheatham-Platinum Stent and Self-Expandable Uncovered Nitinol Stent in patients with Coarctation of Aorta - A Randomized? Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181022041406N3

Enrollment

100

Registered

2019-04-20

Start date

2016-10-22

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coarctation ofaorta. Coarctation of aorta

Interventions

Intervention 1: Intervention group: Coarctoplasty with Self-Expandable Uncovered Nitinol stent. Intervention 2: Intervention group: Coarctoplasty with Cheatham-Platinum Stent.

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with native Corctation of aorta referred to rajaie cardiovascular medical and research center for stenting

Exclusion criteria

Exclusion criteria: Patients with noncircular aortic arch Patients with preductal coarctation Patients with hypoplastic aortic arch Patients with right aberrant subclavian artery Patients with stenosis more than 20 mm in length Patients having aneurysm along with coarctation Patients with common femoral artery and external iliac artery less than 7 mm in diameter

Design outcomes

Primary

Measure	Time frame
Stent migration. Timepoint: During the procedure. Method of measurement: Fluoroscopy.;Aortic perforation. Timepoint: During the procedure. Method of measurement: Angiography.;Procedural success rate. Timepoint: Just after the procedure. Method of measurement: Catheterization.;Access site complication. Timepoint: Just after the procedure. Method of measurement: CT angiography.;Recoarctation. Timepoint: 6 and 12 months after the intervention. Method of measurement: Catheterization.	—

Measure

Time frame

Stent migration. Timepoint: During the procedure. Method of measurement: Fluoroscopy.;Aortic perforation. Timepoint: During the procedure. Method of measurement: Angiography.;Procedural success rate. Timepoint: Just after the procedure. Method of measurement: Catheterization.;Access site complication. Timepoint: Just after the procedure. Method of measurement: CT angiography.;Recoarctation. Timepoint: 6 and 12 months after the intervention. Method of measurement: Catheterization.

—

Secondary

Measure	Time frame
Mortality. Timepoint: During hospitalization. Method of measurement: Questionnaire.;Aneurysm formation. Timepoint: 12 months after intervention. Method of measurement: CT angiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParham Sadeghipour

Rajaie cardiovascular medical and research center

psadeghipour@hotmail.com+98 21 2392 2092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026